The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of Adriamycin cytotoxicity in primary cultures of human breast epithelial cells
- 1 June 1996
- journal article
- other
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 41 (2), 111-122
- https://doi.org/10.1007/bf01807156
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancersEuropean Journal Of Cancer, 1994
- Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF-7 Cellsin vitroandin vivoby Medroxyprogesterone AcetateJapanese Journal of Cancer Research, 1994
- Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Over-expression of P-glycoprotein and glutathione S-transferase PI in MCF-7 cells selected for vincristine resistancein vitroInternational Journal of Cancer, 1992
- Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancerBreast Cancer Research and Treatment, 1990
- Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia CellsJapanese Journal of Cancer Research, 1990
- Adriamycin action on human breast cancer cells: Enhancement by medroxyprogesterone acetateInternational Journal of Cancer, 1989
- Steroid hormones inhibit binding of vinca alkaloid to multidrug resistance related P-glycoproteinBiochemical and Biophysical Research Communications, 1989